Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07315139) titled 'Pentoxifylline on Inflammatory Markers in Non-Diabetic Chronic Kidney Disease Patients' on Dec. 18, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Ain Shams University
Condition:
Pentoxifylline
Inflammatory Markers
Non-Diabetic
Chronic Kidney Disease
Intervention:
Drug: Angiotensin-converting enzyme inhibitors (Ramipril)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: February 1, 2023
Target Sample Size: 42
Countries of Recruitment:
Egypt
To ...